Clinical Trial Update: Prevention Of Recurrence Of Atrial Fibrillation [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial update evaluating prevention of recurrence of atrial fibrillation, sponsored by GlaxoSmithKline. No specific results are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: GlaxoSmithKline | Conditions: Fibrillation, Atrial | Phase 2 | Status: COMPLETED